TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Shareholders' equity (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $52.7B | +4.3% | 9.1% | 9.6% |
| Shareholders' equity (Q2 2026) | $52.7B |
|---|---|
| YoY | +4.3% |
| 5-year CAGR | 9.1% |
| 10-year CAGR | 9.6% |
Shareholders' equity
| Period | Equity | YoY |
|---|---|---|
| 2025 | $53.4B | +7.7% |
| 2024 | $49.6B | +6.1% |
| 2023 | $46.7B | +6.3% |
| 2022 | $44.0B | +7.8% |
| 2021 | $40.8B | +18.2% |
| 2020 | $34.5B | +16.3% |
| 2019 | $29.7B | +7.6% |
| 2018 | $27.6B | +8.6% |
| 2017 | $25.4B | +18.0% |
| 2016 | $21.5B | +0.9% |
| 2015 | $21.4B | +3.9% |
| 2014 | $20.5B | +21.9% |
| 2013 | $16.9B | +9.0% |
| 2012 | $15.5B | +2.8% |
| 2011 | $15.0B | −2.1% |
| 2010 | $15.4B | −0.5% |
| 2009 | $15.4B | +3.4% |
| 2008 | $14.9B | +3.2% |
| 2007 | $14.5B | — |